Tisheeka Graham-Steed1, Edward Uchio, Carolyn K Wells, Mihaela Aslan, John Ko, John Concato. 1. Clinical Epidemiology Research Center, Medical Service, Department of Veterans Affairs Connecticut Healthcare System, West Haven Veterans Affairs Medical Center, West Haven, Conn; Department of Medicine, Yale University School of Medicine, New Haven, Conn.
Abstract
BACKGROUND: Reports suggest worse health-related outcomes among black (vs white) men diagnosed with prostate cancer, but appropriate cause-effect inferences are complicated by the relationship of race and other prognostic factors. METHODS: We searched the literature to find contemporary articles focusing on mortality among black and white men with prostate cancer in equal-access healthcare systems. We also directly assessed the association of race and prostate cancer mortality by conducting an observational cohort analysis of 1270 veterans diagnosed with prostate cancer and followed for 11 to 16 years at 9 medical centers within the Veterans Health Administration. RESULTS: Among 5 reports providing quantitative results for the association of race and mortality among men with prostate cancer in equal-access systems, outcomes were similar for black and white men. Race also was not a prognostic factor in the observational cohort analysis of US veterans, with an adjusted hazard ratio for black (vs white) men and prostate cancer mortality of 0.90 (95% confidence interval, 0.58-1.40; P = .65). CONCLUSIONS: Mortality among black and white patients with prostate cancer is similar in equal-access healthcare systems. Studies that find racial differences in mortality (including cause-specific mortality) among men with prostate cancer may not account fully for socioeconomic and clinical factors. Published by Elsevier Inc.
BACKGROUND: Reports suggest worse health-related outcomes among black (vs white) men diagnosed with prostate cancer, but appropriate cause-effect inferences are complicated by the relationship of race and other prognostic factors. METHODS: We searched the literature to find contemporary articles focusing on mortality among black and white men with prostate cancer in equal-access healthcare systems. We also directly assessed the association of race and prostate cancer mortality by conducting an observational cohort analysis of 1270 veterans diagnosed with prostate cancer and followed for 11 to 16 years at 9 medical centers within the Veterans Health Administration. RESULTS: Among 5 reports providing quantitative results for the association of race and mortality among men with prostate cancer in equal-access systems, outcomes were similar for black and white men. Race also was not a prognostic factor in the observational cohort analysis of US veterans, with an adjusted hazard ratio for black (vs white) men and prostate cancer mortality of 0.90 (95% confidence interval, 0.58-1.40; P = .65). CONCLUSIONS: Mortality among black and white patients with prostate cancer is similar in equal-access healthcare systems. Studies that find racial differences in mortality (including cause-specific mortality) among men with prostate cancer may not account fully for socioeconomic and clinical factors. Published by Elsevier Inc.
Entities:
Keywords:
Delivery of health care; Ethnic groups; Healthcare disparities; Prostatic neoplasms; Race
Authors: Paula A Braveman; Catherine Cubbin; Susan Egerter; Sekai Chideya; Kristen S Marchi; Marilyn Metzler; Samuel Posner Journal: JAMA Date: 2005-12-14 Impact factor: 56.272
Authors: Jacob H Cohen; Victor J Schoenbach; Jay S Kaufman; James A Talcott; Anna P Schenck; Sharon Peacock; Michael Symons; M Ahinee Amamoo; William R Carpenter; Paul A Godley Journal: Cancer Causes Control Date: 2006-08 Impact factor: 2.506
Authors: P N Brawn; E H Johnson; D L Kuhl; M W Riggs; V O Speights; C F Johnson; P P Pandya; M L Lind; N F Bell Journal: Cancer Date: 1993-04-15 Impact factor: 6.860
Authors: Kim Peterson; Johanna Anderson; Erin Boundy; Lauren Ferguson; Ellen McCleery; Kallie Waldrip Journal: Am J Public Health Date: 2018-03 Impact factor: 9.308
Authors: Jonathan Pastrana Del Valle; Nathanael R Fillmore; George Molina; Mark Fairweather; Jiping Wang; Thomas E Clancy; Stanley W Ashley; Richard D Urman; Edward E Whang; Jason S Gold Journal: Ann Surg Oncol Date: 2022-01-10 Impact factor: 5.344
Authors: Ericka M Sohlberg; I-Chun Thomas; Jaden Yang; Kristopher Kapphahn; Timothy J Daskivich; Ted A Skolarus; Jeremy B Shelton; Danil V Makarov; Jonathan Bergman; Christine Ko Bang; Mary K Goldstein; Todd H Wagner; James D Brooks; Manisha Desai; John T Leppert Journal: Urol Oncol Date: 2020-07-13 Impact factor: 3.498
Authors: Brian Thomas Joyce; Tao Gao; Lei Liu; Yinan Zheng; Siran Liu; Wei Zhang; Frank Penedo; Qi Dai; Joel Schwartz; Andrea A Baccarelli; Lifang Hou Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-08-11 Impact factor: 4.254
Authors: Curtis Bryant; Bradford S Hoppe; Randal H Henderson; Romaine C Nichols; William M Mendenhall; Tamara L Smith; Christopher G Morris; Christopher R Williams; Zhong Su; Zuofeng Li; Nancy P Mendenhall Journal: Int J Part Ther Date: 2017-07-11